Drug factory · FDA FEI 3006895951
Shanghai Desano Chemical Pharmaceutical Co., Ltd
No. 417 Binhai Rd. Laogang Town, Pudong New Area, Shanghai, China
Problems found, fixed voluntarily at FDA's last inspection, Nov 17, 2023.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
5 drug inspections on record since 2009: 1 with no problems, 3 with problems fixed voluntarily, 1 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Ritonavir | Makes the active ingredient | Cipla USA., Inc. | 69097-655 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Nov 17, 2023 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| Mar 10, 2017 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
| May 7, 2015 | Serious problems, FDA action | Drug Quality Assurance | — |
| Jun 7, 2012 | No problems found | Drug Quality Assurance | — |
| Apr 24, 2009 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: api manufacture.